Literature DB >> 8935606

'Relapse' of chronic active hepatitis--not always what it seems.

A F Muller1, P J Toghill, P Smith.   

Abstract

Immune chronic active hepatitis is a disease notorious for its unpredictability. In a patient with chronic hepatitis who has already suffered relapses a search for a second cause of jaundice is not usually necessary. This report emphasises the essential role of liver biopsy.

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8935606      PMCID： PMC2398514          DOI： 10.1136/pgmj.72.849.431

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN： 0032-5473            Impact factor:   2.401


  5 in total

1.  Controlled trial of prednisone and azathioprine in active chronic hepatitis.

Authors:  I M Murray-Lyon; R B Stern; R Williams
Journal:  Lancet       Date:  1973-04-07       Impact factor: 79.321

2.  Clinical, biochemical, and histological remission of severe chronic active liver disease: a controlled study of treatments and early prognosis.

Authors:  R D Soloway; W H Summerskill; A H Baggenstoss; M G Geall; G L Gitnićk; I R Elveback; L J Schoenfield
Journal:  Gastroenterology       Date:  1972-11       Impact factor: 22.682

3.  Diflunisal-induced cholestatic jaundice.

Authors:  J S Warren
Journal:  Br Med J       Date:  1978-09-09

4.  The role of non-steroidal anti-inflammatory drugs in acute liver injury.

Authors:  L A García Rodríguez; S Pérez Gutthann; A M Walker; L Lueck
Journal:  BMJ       Date:  1992-10-10

5.  Anti-GOR and hepatitis C virus in autoimmune liver diseases.

Authors:  G Michel; A Ritter; G Gerken; K H Meyer zum Büschenfelde; R Decker; M P Manns
Journal:  Lancet       Date:  1992-02-01       Impact factor: 79.321
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.